Featured News

Dr. Esen Sefik, PhD, an immunologist and an Associate Research Scientist in the Flavell Lab at Yale School of Medicine, is the recipient of the Celiac Disease Foundation–Takeda Early Career Research Award, an award designed to support promising early-career researchers working toward independent and productive research careers in celiac disease.  

As the mother of a child with celiac disease, I understand the mix of emotions that Halloween can bring for our community. Navigating school, parties, and trick-or-treating with a child with celiac disease comes with its own set of concerns.

The Celiac Disease Foundation, a world leader in patient advocacy, and Takeda Development Center Americas, a global biopharmaceutical leader, today are proud to announce the Celiac Disease Foundation–Takeda Early Career Research Award.

One of our most important research investments over the last several years has been in iCureCeliac®, the nation’s celiac disease patient registry. This month, researchers published three important studies that used iCureCeliac® as the data source.

The Celiac Disease Foundation National Patient Advocacy Summit in Washington, DC will train participants to advocate on celiac disease public policy priorities to Members of Congress.

Cour Pharmaceuticals has announced a $420 million licensing deal with Takeda Pharmaceuticals following a favorable outcome of their phase 2 trial for celiac disease. The company released data from a…